Ipamorelin (GHSR-1a Selective Pentapeptide)
The most selective GHSR-1a pentapeptide on the shelf — tested every lot.
Drag the vial to rotate the label
This compound is not currently available for purchase. Submit a request to help guide future inventory and testing priorities.
The most selective GHSR-1a pentapeptide on the shelf — tested every lot.
Ipamorelin is a synthetic pentapeptide and a highly selective agonist of the growth hormone secretagogue receptor (GHSR-1a, ghrelin receptor). Its selectivity relative to broader GH-secretagogues makes it a common tool compound in cultured somatotroph and pituitary-cell models, particularly for parallel GHSR-1a receptor engagement and downstream cAMP / IP₃ signaling without prolactin or cortisol confounders. Supplied as a sterile lyophilized powder for reconstitution in bacteriostatic water. For laboratory research use only — not for human or veterinary use.
- GHSR-1a receptor binding
- Somatotroph cAMP / IP₃ signaling
- Selective GH-secretagogue comparison assays
- Independently verified for identity and purity on a batch-specific basis.
- Certificates of analysis publicly accessible by lot ID — never averaged.
- Sourced through qualified manufacturing partners and shipped from the United States.
- Fast shipping, always tracked, shipped from the United States.
Research and documentation
Where this lot is in the release process
- 01
Backorder confirmed
Your product is reserved from the incoming lot.
- 02
Arriving for testing · ~6 days
Incoming lot is expected to reach our testing queue within 6 days.
- 03
Sample en route to lab
A representative sample is being sent for independent analytical testing.
- 04
Independent testing · 3–5 days
Identity, purity, and applicable analytical testing are completed.
- 05
Results verified
Results are reviewed and the certificate of analysis is published.
- 06
Ready to ship
Verified inventory is released and your order is prepared for shipment.
Timeframes are estimates. No certificate from another lot is substituted while testing is in progress.
